Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Journal of Neurochemistry
|
March 12, 2010
Molecular and cellular characterization of Neuregulin-1 type IV isoforms
Alon Shamir, Andres Buonanno
Harefuah
|
June 21, 2002
[Research approaches in the behavioral genetics of psychiatric disorders]
Alon Shamir, Galit Shaltiel
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 21, 2002
Intracerebroventricular antisense to inositol monophosphatase-1 reduces enzyme activity but does not affect Li-sensitive behavior
Alon Shamir, Galit Shaltiel, Galila Agam
Journal of Psychiatric Research
|
October 1, 2022
What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies
Fadwa Dabbah-Assadi, Ran Handel, Alon Shamir
The International Journal of Social Psychiatry
|
February 3, 2021
Patients' attitudes toward conventional and herbal treatments for depression and anxiety: A cross-sectional Israeli survey
Or Burstein, Alon Shamir, Nurit Abramovitz, et al.
Bipolar Disorders
|
December 14, 2002
Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs
Galila Agam, Alon Shamir, Galit Shaltiel, et al.
Bipolar Disorders
|
January 19, 2005
Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder
Alon Shamir, Naama Elhadad, Robert H Belmaker, et al.
Behavioural Brain Research
|
March 13, 2017
Behavioral characterization of blocking the ErbB signaling during adolescent and adulthood in reward-liking (preference) and reward-related learning
Hagar Tadmor, Idit Golani, Eshkar Dvir, et al.
The International Journal of Neuropsychopharmacology
|
December 20, 2005
Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder
Galit Shaltiel, Alon Shamir, Itzhak Levi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 19, 2017
ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers
Hagar Tadmor, Idit Golani, Ravid Doron, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Journal of Neurochemistry
|
March 12, 2010
Molecular and cellular characterization of Neuregulin-1 type IV isoforms
Alon Shamir, Andres Buonanno
Harefuah
|
June 21, 2002
[Research approaches in the behavioral genetics of psychiatric disorders]
Alon Shamir, Galit Shaltiel
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 21, 2002
Intracerebroventricular antisense to inositol monophosphatase-1 reduces enzyme activity but does not affect Li-sensitive behavior
Alon Shamir, Galit Shaltiel, Galila Agam
Journal of Psychiatric Research
|
October 1, 2022
What we know about the role of corticosteroids in psychiatric disorders; evidence from animal and clinical studies
Fadwa Dabbah-Assadi, Ran Handel, Alon Shamir
The International Journal of Social Psychiatry
|
February 3, 2021
Patients' attitudes toward conventional and herbal treatments for depression and anxiety: A cross-sectional Israeli survey
Or Burstein, Alon Shamir, Nurit Abramovitz, et al.
Bipolar Disorders
|
December 14, 2002
Myo-inositol-1-phosphate (MIP) synthase: a possible new target for antibipolar drugs
Galila Agam, Alon Shamir, Galit Shaltiel, et al.
Bipolar Disorders
|
January 19, 2005
Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder
Alon Shamir, Naama Elhadad, Robert H Belmaker, et al.
Behavioural Brain Research
|
March 13, 2017
Behavioral characterization of blocking the ErbB signaling during adolescent and adulthood in reward-liking (preference) and reward-related learning
Hagar Tadmor, Idit Golani, Eshkar Dvir, et al.
The International Journal of Neuropsychopharmacology
|
December 20, 2005
Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder
Galit Shaltiel, Alon Shamir, Itzhak Levi, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 19, 2017
ErbB signaling antagonist ameliorates behavioral deficit induced by phencyclidine (PCP) in mice, without affecting metabolic syndrome markers
Hagar Tadmor, Idit Golani, Ravid Doron, et al.
Page
of 5